Learn about the regulatory challenges facing the cannabis industry and how to prepare your company for future regulations.
The cannabis industry is facing a very fragmented regulatory landscape. Some countries have already adopted federal requirements, while others are still figuring out how the industry should be regulated. In some instances, state and local lawmakers have enacted cannabis product legislation.
The discussion will include:
About the Presenters:
- Industry challenges
- Regulations and compliance overview
- Examples of FDA findings
Joeseph Cassella, Director of Regulatory Compliance, USDM Life Sciences
Joe has over 20 years of experience in the Pharmaceutical, Biotech and Medical Device industries. His focus has been on the IT/Design/Application/Validation and delivery of systems across organizations. He has led projects that touch on most of the functions of the industry inclusive of IT Infrastructure, Research & Development, QA/QC, Manufacturing, Compliance, and Sales & Marketing. All while staying abreast of the changing regulatory environment.
Donald Zinn, Director of Emerging Compliance, USDM Life Sciences
Don provides validation and compliance leadership for USDM’s emerging clients with over 22 years of quality, compliance and systems validation experience. Don has experience working with various GXP organizations that provide services in the areas of blood banking, central laboratory testing, and clinical development. Don’s focus is assisting emerging clients in the Life Sciences industry to become compliant with best industry practices and regulatory guidelines while minimizing risk to patients and data.